It is not normal for experimental albino rats to become dizzy after receiving their first oral dose, and it may be a cause for concern. Dizziness can be a sign of a variety of conditions, such as neurological problems, ear infections, or vestibular disorders.
If you are conducting an experiment on albino rats, it is important to monitor their behavior closely and document any adverse effects that they experience. If the dizziness persists or is accompanied by other symptoms, such as loss of appetite, lethargy, or difficulty moving, it is advisable to consult a veterinarian or a qualified research professional.
It's important to note that the dosages used in animal studies should be carefully selected to avoid toxicity, and the animal's welfare should be a top priority throughout the experiment. If you have any concerns about the experimental protocol, it is advisable to consult with a qualified research professional or an institutional animal care and use committee (IACUC) to ensure that the study is conducted in a responsible and ethical manner.